This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Dose Optimization of Gotistobart + Pembro in Platinum-Resistant Ovarian Cancer - PRESERVE-004/GOG-3081 Study

37 views
October 16, 2024
Comments 0
Login to view comments. Click here to Login